Nir Eyal
Rutgers, The State University of New Jersey
H-index: 26
North America-United States
Top articles of Nir Eyal
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Ethical Issues in Disaster Medicine | Koenig and Schultz's Disaster Medicine: Comprehensive Principles and Practices | George J Annas KL Koenig CH Schultz | 2016/4/18 |
Research ethics and public trust in vaccines: the case of COVID-19 challenge trials | Journal of Medical Ethics | Nir Eyal | 2024/4/1 |
Future pandemics and the urge to ‘do something’ | Journal of Medical Ethics | Adam Lerner Nir Eyal | 2024/1/29 |
The phantasm of zero suicide | The British Journal of Psychiatry | Manne Sjöstrand Nir Eyal | 2023/6 |
Why Dropping Most COVID-19 Vaccine Mandates Is Now Ethical | Health Affairs Forefront | Nir Eyal Matthew K Wynia Thomas D Harter Debra DeBruin Jason T Eberl | 2023 |
Mass drug administration of azithromycin: an analysis | Rebecca Kahn Nir Eyal Samba O Sow Marc Lipsitch | 2023/3/1 | |
Joint statement in support of hepatitis C human challenge studies | The Lancet Gastroenterology & Hepatology | Harvey J Alter Eleanor Barnes Mia J Biondi Andrea L Cox Jake D Eberts | 2023/11/1 |
Input and output in distributive theory | Noûs | Nir Eyal Anders Herlitz | 2023/3 |
When offering a patient beneficial treatment undermines public health | Bioethics | Nir Eyal Bridget Williams | 2023/11 |
Ethical and legal race‐responsive vaccine allocation | Bioethics | Bastian Steuwer Nir Eyal | 2023/10 |
All research that might result in a pandemic must undergo external review | Nir Eyal | 2023/3 | |
Pandemic vaccine testing: Combining conventional and challenge studies | Pharmacoepidemiology and drug safety | Tobias Gerhard Brian L Strom Nir Eyal | 2022/6 |
Do coronavirus vaccine challenge trials have a distinctive generalisability problem? | Journal of medical ethics | Nir Eyal Tobias Gerhard | 2022/9/1 |
The ethics of human challenge trials using emerging Severe Acute Respiratory Syndrome 2 Variants | The Journal of Infectious Diseases | Abie Rohrig Nir Eyal | 2022/3/15 |
The ethical case for placebo control in HIV-cure-related studies with ART interruption | Journal of Virus Eradication | Monica Magalhaes Daniel R Kuritzkes Nir Eyal | 2022/9/1 |
COVID vaccine efficacy against the B. 1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies | Human Vaccines & Immunotherapeutics | Nir Eyal Arthur Caplan Stanley Plotkin | 2022/1/31 |
Coronavirus disease 2019 (COVID-19) vaccine prioritization in low-and middle-income countries may justifiably depart from high-income countries’ age priorities | Clinical Infectious Diseases | Nir Eyal Anca Gheaus Axel Gosseries Monica Magalhaes Thierry Ngosso | 2022/8/15 |
Paired Publication: A Way to Lower One Barrier between Philosophical Insight and Bioethics | The American Journal of Bioethics | Bastian Steuwer Nir Eyal Monica Magalhães | 2022/12/2 |
“The research assistants kept coming to follow me up; I counted myself as a lucky person”: Social support arising from a longitudinal HIV cohort study in Uganda | Plos one | Jeffrey I Campbell Angella Musiimenta Sylvia Natukunda Nir Eyal Jessica E Haberer | 2022/1/25 |
Consent requirements for testing health policies: An intercontinental comparison of expert opinions | Journal of Empirical Research on Human Research Ethics | Astrid Berner-Rodoreda Shannon McMahon Nir Eyal Puspita Hossain Atonu Rabbani | 2022/7 |
